APA (7th ed.) Citation

L, M., V, B., S, B., M, C., R, C., P, C., . . . A, R. (2021). The risk of infection in patients with multiple sclerosis treated with disease-modifying therapies: A Delphi consensus statement. Multiple sclerosis (Houndmills, Basingstoke, England), 27(3), 331. https://doi.org/10.1177/1352458520952311

Chicago Style (17th ed.) Citation

L, Moiola, et al. "The Risk of Infection in Patients with Multiple Sclerosis Treated with Disease-modifying Therapies: A Delphi Consensus Statement." Multiple Sclerosis (Houndmills, Basingstoke, England) 27, no. 3 (2021): 331. https://doi.org/10.1177/1352458520952311.

MLA (9th ed.) Citation

L, Moiola, et al. "The Risk of Infection in Patients with Multiple Sclerosis Treated with Disease-modifying Therapies: A Delphi Consensus Statement." Multiple Sclerosis (Houndmills, Basingstoke, England), vol. 27, no. 3, 2021, p. 331, https://doi.org/10.1177/1352458520952311.